Investments in and Advances to Unconsolidated Joint Ventures

9 Months Ended

Sep. 30, 2017

Equity Method Investments and Joint Ventures [Abstract]

Investments in and Advances to Unconsolidated Joint Ventures

Investments in and Advances to Unconsolidated Joint Ventures

The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):

				Carrying Amount
				September 30,		December 31,
Entity(1)	Segment	Ownership%		2017		2016
CCRC JV(2)	SHOP		49	$	427,159	$	439,449
RIDEA II	SHOP		40	257,766		—
Life Science JVs(3)	Life science		50 - 63	64,111		67,879
MBK JV(2)	SHOP		50	38,366		38,909
Development JVs(5)	SHOP		50 - 90	19,867		10,459
Medical Office JVs(4)	Medical office		20 - 67	13,620		13,438
K&Y JVs(6)	Other non-reportable segments		80	1,465		1,342
Advances to unconsolidated joint ventures, net				15		15
				$	822,369	$	571,491

_______________________________________

(1) These entities are not consolidated because the Company does not control, through voting rights or other means, the JV.

(2) Includes two unconsolidated JVs in a RIDEA structure (PropCo and OpCo).

(3) Includes the following unconsolidated partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

(4) Includes three unconsolidated medical office partnerships (and the Company’s ownership percentage): HCP Ventures IV, LLC (20%); HCP Ventures III, LLC (30%); and Suburban Properties, LLC (67%).

(5) Includes four unconsolidated SHOP development partnerships (and the Company’s ownership percentage): (i) Vintage Park Development JV (85%); (ii) Waldwick JV (85%); (iii) Otay Ranch JV (90%); and (iv) MBK Development JV (50%).

(6) Includes three unconsolidated joint ventures.

See Note 1 for further information on the deconsolidation of RIDEA II.